Our Impact in 2025
CSL’s Impact Report is more than numbers, it highlights our work to create lifesaving medicines, safeguard public health, advance science, and contribute positively to the communities where we live and work. Together, these efforts reflect the core Values of CSL and build a legacy of health and hope, delivering enduring patient impact around the world.
-
8.8m
patients treated with plasma-derived and recombinant therapies
-
>101m
seasonal flu vaccines distributed globally
-
$24m
contributed to support patient communities
-
US $XX million
in donations to science and innovation to advance knowledge, research and careers in biomedicine.
-
3X
new product registrations and indications in 2023/24 providing more treatment options to patients with serious diseases
-
XX
clinical trials underway (across clinical, registration and post launch) to find solutions to unmet needs
Our Businesses
Delivering Lifesaving & Life Changing Medicines
We hear directly from patients and their families about the life-changing impact of receiving the right medicine.
A Positive Legacy in Local Communities
We actively support initiatives that improve the health or science education of the communities where we live and work, and we are there to help in times of emergency.
